Ghrelin is far more than a hunger hormone—it regulates immunity, brain health, cardiovascular function, and bone

Modern research reveals ghrelin as a pleiotropic peptide regulating feeding, growth hormone, glucose homeostasis, cardiovascular tone, bone remodeling, immunity, neuroprotection, and even addiction, making the ghrelin-GHSR1a axis a major drug target.

Polishchuk, Hlafira et al.·International journal of molecular sciences·2025·Moderate EvidenceNarrative Review
RPEP-13073Narrative ReviewModerate Evidence2025RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Narrative Review
Evidence
Moderate Evidence
Sample
N=N/A (review)
Participants
N/A

What This Study Found

Ghrelin acts as a pleiotropic regulator across feeding, GH release, glucose homeostasis, cardiovascular tone, bone remodeling, immunity, neuroprotection, and addiction. Cryo-EM structures reveal bipartite GHSR1a binding pocket enabling biased signaling. Des-acyl ghrelin and mini-ghrelins have distinct, context-dependent effects. LEAP-2 and GOAT inhibitors are emerging therapeutic strategies.

Key Numbers

No specific clinical trial data; reviews structural and functional data from preclinical and clinical literature.

How They Did This

Comprehensive narrative review synthesizing structural biology, signaling, physiology, and therapeutic development of the ghrelin system.

Why This Research Matters

Understanding ghrelin's full scope of activity—far beyond hunger—opens multiple therapeutic avenues. The ghrelin system could be targeted for obesity, inflammatory diseases, neuropsychiatric conditions, and addiction, representing a major druggable axis in the post-GLP-1 era.

The Bigger Picture

As GLP-1 drugs dominate metabolic medicine, ghrelin and its regulatory system (including LEAP-2 and GOAT) represent the next frontier. Structural insights into biased signaling at GHSR1a could enable precision therapeutics that activate beneficial pathways while avoiding unwanted effects.

What This Study Doesn't Tell Us

Narrative review without systematic methodology. Many emerging applications are based on preclinical data. Clinical translation of ghrelin-based therapeutics has been slow despite strong preclinical rationale.

Questions This Raises

  • ?Can biased GHSR1a agonists achieve therapeutic selectivity for specific ghrelin pathways?
  • ?Will LEAP-2-based strategies prove effective for appetite control in clinical trials?
  • ?How does ghrelin system modulation interact with GLP-1 agonist therapy?

Trust & Context

Key Stat:
Beyond hunger Ghrelin regulates at least 8 major physiological systems through GHSR1a signaling, with emerging roles in neuroprotection and addiction
Evidence Grade:
Comprehensive narrative review synthesizing structural, preclinical, and clinical evidence. Strong mechanistic foundation but many applications remain preclinical.
Study Age:
Published in 2025; incorporates latest cryo-EM structural data and emerging therapeutic approaches.
Original Title:
Beyond Hunger: The Structure, Signaling, and Systemic Roles of Ghrelin.
Published In:
International journal of molecular sciences, 26(22) (2025)
Database ID:
RPEP-13073

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study

Summarizes existing research without a strict systematic method.

What do these levels mean? →

Frequently Asked Questions

What does ghrelin do besides making you hungry?

Ghrelin regulates far more than appetite: it influences growth hormone release, blood sugar control, heart function, bone health, immune responses, brain protection, stress responses, and even addiction. It's now considered one of the most versatile hormones in the body.

Could ghrelin-based drugs treat diseases beyond obesity?

Potentially yes. Research suggests targeting the ghrelin receptor (GHSR1a) could help with inflammatory diseases, Alzheimer's disease, depression, addiction, and bone disorders. New structural insights are enabling the design of drugs that activate specific beneficial pathways without unwanted side effects.

Read More on RethinkPeptides

Cite This Study

RPEP-13073·https://rethinkpeptides.com/research/RPEP-13073

APA

Polishchuk, Hlafira; Guzik, Krzysztof; Kantyka, Tomasz. (2025). Beyond Hunger: The Structure, Signaling, and Systemic Roles of Ghrelin.. International journal of molecular sciences, 26(22). https://doi.org/10.3390/ijms262210996

MLA

Polishchuk, Hlafira, et al. "Beyond Hunger: The Structure, Signaling, and Systemic Roles of Ghrelin.." International journal of molecular sciences, 2025. https://doi.org/10.3390/ijms262210996

RethinkPeptides

RethinkPeptides Research Database. "Beyond Hunger: The Structure, Signaling, and Systemic Roles ..." RPEP-13073. Retrieved from https://rethinkpeptides.com/research/polishchuk-2025-beyond-hunger-the-structure

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.